$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

$nhc Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-K Financial Statement

#000143774918002879 Filed on February 20, 2018

Income Statement

Concept	2016 Q4	2016 Q3	2016 Q2
Revenue	$238.0M	$231.3M	$227.8M
YoY Change	1.74%	2.62%	1.27%
Cost Of Revenue	$142.5M	$140.4M	$135.1M
YoY Change	1.79%	3.92%	2.43%
Gross Profit	$92.40M	$90.90M	$92.70M
YoY Change	-1.7%	0.66%	-0.32%
Gross Profit Margin	38.82%	39.3%	40.7%
Selling, General & Admin	$10.30M	$10.30M	$10.30M
YoY Change	3.0%	3.0%	3.0%
% of Gross Profit	11.15%	11.33%	11.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.20M	$10.00M	$9.400M
YoY Change	5.15%	8.7%	1.08%
% of Gross Profit	11.04%	11.0%	10.14%
Operating Expenses	$73.80M	$79.30M	$77.10M
YoY Change	1.23%	4.48%	0.52%
Operating Profit	$17.69M	$10.59M	$14.64M
YoY Change	-12.54%	-23.04%	-6.78%
Interest Expense	$3.900M	$1.020M	$939.0K
YoY Change	-11.36%	71.72%	57.02%
% of Operating Profit	22.05%	9.63%	6.41%
Other Income/Expense, Net	$4.876M	$5.091M	$4.925M
YoY Change	-7.05%	11.89%	19.25%
Pretax Income	$22.60M	$15.68M	$19.57M
YoY Change	-11.37%	-14.36%	-1.36%
Income Tax	$8.700M	$4.571M	$7.700M
% Of Pretax Income	38.5%	29.15%	39.35%
Net Earnings	$13.86M	$11.11M	$11.87M
YoY Change	-7.43%	-11.59%	-3.98%
Net Earnings / Revenue	5.82%	4.8%	5.21%
Basic Earnings Per Share	$0.92	$0.73	$0.78
Diluted Earnings Per Share	$0.91	$0.73	$0.78
COMMON SHARES
Basic Shares Outstanding		15.20M	15.27M
Diluted Shares Outstanding		15.22M	15.29M

Balance Sheet

Concept	2016 Q4	2016 Q3	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$164.3M	$166.2M	$179.3M
YoY Change	6.41%	-8.33%	-5.33%
Cash & Equivalents	$26.34M	$19.21M	$37.54M
Short-Term Investments	$138.0M	$147.0M	$141.8M
Other Short-Term Assets	$28.50M	$30.50M	$30.70M
YoY Change	-2.73%	4.1%	3.72%
Inventory	$7.508M	$7.446M	$7.137M
Prepaid Expenses
Receivables	$82.53M	$76.65M	$77.23M
Other Receivables	$8.000M	$6.400M	$2.900M
Total Short-Term Assets	$290.9M	$287.2M	$297.3M
YoY Change	4.27%	-6.01%	-3.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$559.6M	$557.7M	$553.3M
YoY Change	4.4%	5.97%	6.49%
Goodwill	$17.60M	$17.60M	$17.60M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$37.20M	$36.60M	$36.00M
YoY Change	-1.33%	4.87%	2.56%
Other Assets	$237.0M	$243.5M	$237.0M
YoY Change	2.88%	-2.79%	31.57%
Total Long-Term Assets	$796.6M	$801.1M	$790.3M
YoY Change	3.94%	3.14%	3.24%
TOTAL ASSETS
Total Short-Term Assets	$290.9M	$287.2M	$297.3M
Total Long-Term Assets	$796.6M	$801.1M	$790.3M
Total Assets	$1.087B	$1.088B	$1.088B
YoY Change	4.03%	0.56%	1.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.60M	$17.40M	$21.80M
YoY Change	-7.46%	8.07%	27.49%
Accrued Expenses	$91.80M	$78.10M	$77.60M
YoY Change	-0.65%	-9.19%	2.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$3.400M	$3.400M
YoY Change		6.25%	6.25%
Total Short-Term Liabilities	$150.9M	$142.8M	$140.8M
YoY Change	0.18%	-20.97%	-17.64%
LONG-TERM LIABILITIES
Long-Term Debt	$120.0M	$120.0M	$120.0M
YoY Change	0.0%	1100.0%	186.4%
Other Long-Term Liabilities	$16.30M	$16.21M	$17.37M
YoY Change	0.05%	-3.15%	-85.31%
Total Long-Term Liabilities	$136.3M	$136.2M	$137.4M
YoY Change	0.01%	409.44%	-14.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$150.9M	$142.8M	$140.8M
Total Long-Term Liabilities	$136.3M	$136.2M	$137.4M
Total Liabilities	$417.8M	$279.0M	$278.2M
YoY Change	45.61%	34.51%	-15.95%
SHAREHOLDERS EQUITY
Retained Earnings	$391.9M	$384.9M	$380.6M
YoY Change	6.5%	7.1%
Common Stock	$152.0K	$152.0K	$153.0K
YoY Change	1.33%	6.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$669.6M	$670.8M	$671.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.087B	$1.088B	$1.088B
YoY Change	4.03%	0.56%	1.3%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2016 Q2
OPERATING ACTIVITIES
Net Income	$13.86M	$11.11M	$11.87M
YoY Change	-7.43%	-11.59%	-3.98%
Depreciation, Depletion And Amortization	$10.20M	$10.00M	$9.400M
YoY Change	5.15%	8.7%	1.08%
Cash From Operating Activities	$26.10M	$18.40M	$22.10M
YoY Change	29.85%	-20.35%	39.87%
INVESTING ACTIVITIES
Capital Expenditures	-$12.10M	-$14.40M	-$22.70M
YoY Change	-37.63%	-10.0%	118.27%
Acquisitions
YoY Change
Other Investing Activities	-$12.30M	-$5.800M	-$2.600M
YoY Change	108.47%	163.64%	-48.0%
Cash From Investing Activities	-$24.40M	-$20.20M	-$25.30M
YoY Change	-3.94%	11.6%	64.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-6.500M	-16.00M	-6.300M
YoY Change	-75.75%	175.86%	-10.0%
NET CHANGE
Cash From Operating Activities	26.10M	18.40M	22.10M
Cash From Investing Activities	-24.40M	-20.20M	-25.30M
Cash From Financing Activities	-6.500M	-16.00M	-6.300M
Net Change In Cash	-4.800M	-17.80M	-9.500M
YoY Change	-85.05%	2125.0%	43.94%
FREE CASH FLOW
Cash From Operating Activities	$26.10M	$18.40M	$22.10M
Capital Expenditures	-$12.10M	-$14.40M	-$22.70M
Free Cash Flow	$38.20M	$32.80M	$44.80M
YoY Change	-3.29%	-16.11%	70.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-44000
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	90000000
CY2017	nhc	Annual Excess Coverage AnnualExcessCoverage	9000000
CY2017	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	-1097000
CY2017	nhc	Direct Business Coverage Statutory Limits DirectBusinessCoverageStatutoryLimits	1000000
CY2007Q3	nhc	Dividend Distribution Rights DividendDistributionRights	1
CY2016	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	59000
CY2017Q4	nhc	Cost To Complete Construction In Progress CostToCompleteConstructionInProgress	11441000
CY2017Q4	nhc	Deferred Tax Assets Non Refundable Entrance Fees DeferredTaxAssetsNonRefundableEntranceFees	121000
CY2016Q4	nhc	Deferred Tax Assets Non Refundable Entrance Fees DeferredTaxAssetsNonRefundableEntranceFees	211000
CY2017Q4	nhc	Deferred Tax Assets Refundable Entrance Fees DeferredTaxAssetsRefundableEntranceFees
CY2016Q4	nhc	Deferred Tax Assets Refundable Entrance Fees DeferredTaxAssetsRefundableEntranceFees	1923000
CY2017	nhc	Deferred Tax Expense Change In Federal Tax Rate DeferredTaxExpenseChangeInFederalTaxRate	2854000
CY2017Q4	nhc	Deferred Tax Liabilities Book Basis In Excess Of Tax Basis Of Securities DeferredTaxLiabilitiesBookBasisInExcessOfTaxBasisOfSecurities	1585000
CY2016Q4	nhc	Deferred Tax Liabilities Book Basis In Excess Of Tax Basis Of Securities DeferredTaxLiabilitiesBookBasisInExcessOfTaxBasisOfSecurities	2416000
CY2017Q4	nhc	Deferred Tax Liabilities Long Term Investments DeferredTaxLiabilitiesLongTermInvestments	2775000
CY2016Q4	nhc	Deferred Tax Liabilities Long Term Investments DeferredTaxLiabilitiesLongTermInvestments	3404000
CY2017Q4	nhc	Deferred Tax Liabilities Unrealized Gains On Marketable Securities DeferredTaxLiabilitiesUnrealizedGainsOnMarketableSecurities	28278000
CY2016Q4	nhc	Deferred Tax Liabilities Unrealized Gains On Marketable Securities DeferredTaxLiabilitiesUnrealizedGainsOnMarketableSecurities	41264000
CY2017	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	7033000
CY2016	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	7324000
CY2015	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	6809000
CY2016	nhc	Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Amount EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsAmount	1368000
CY2015	nhc	Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Amount EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsAmount	2141000
CY2017	nhc	Effective Income Tax Rate Reconciliation Insurance Expense Amount EffectiveIncomeTaxRateReconciliationInsuranceExpenseAmount	-103000
CY2016	nhc	Effective Income Tax Rate Reconciliation Insurance Expense Amount EffectiveIncomeTaxRateReconciliationInsuranceExpenseAmount	27000
CY2015	nhc	Effective Income Tax Rate Reconciliation Insurance Expense Amount EffectiveIncomeTaxRateReconciliationInsuranceExpenseAmount	6000
CY2017	nhc	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount	-237000
CY2016	nhc	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount
CY2015	nhc	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount
CY2015	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	-354000
CY2017	nhc	Equity Method Investment Summarized Financial Information Expenses EquityMethodInvestmentSummarizedFinancialInformationExpenses	45718000
CY2016	nhc	Equity Method Investment Summarized Financial Information Expenses EquityMethodInvestmentSummarizedFinancialInformationExpenses	42928000
CY2015	nhc	Equity Method Investment Summarized Financial Information Expenses EquityMethodInvestmentSummarizedFinancialInformationExpenses	40875000
CY2017Q4	nhc	Homecare Services Anticipated Payment Deferred Revenue Percentage HomecareServicesAnticipatedPaymentDeferredRevenuePercentage	0.6
CY2017	nhc	Increase Decrease In Continuing Care Retirement Communities Obligation For Future Services Amount IncreaseDecreaseInContinuingCareRetirementCommunitiesObligationForFutureServicesAmount	-349000
CY2016	nhc	Increase Decrease In Continuing Care Retirement Communities Obligation For Future Services Amount IncreaseDecreaseInContinuingCareRetirementCommunitiesObligationForFutureServicesAmount	-204000
CY2015	nhc	Increase Decrease In Continuing Care Retirement Communities Obligation For Future Services Amount IncreaseDecreaseInContinuingCareRetirementCommunitiesObligationForFutureServicesAmount	-487000
CY2017	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	370000
CY2016	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	365000
CY2015	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	-6277000
CY2014Q1	nhc	Initial Lease Term InitialLeaseTerm	P10Y
CY2017	nhc	Noncontrolling Interest Increase From Capital Contribution NoncontrollingInterestIncreaseFromCapitalContribution	1217000
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	15978000
CY2014Q1	nhc	Number Of Additional Lease Options NumberOfAdditionalLeaseOptions	2
CY2010Q4	nhc	Number Of Additional Lease Options NumberOfAdditionalLeaseOptions	5
CY2014Q1	nhc	Number Of Capitalized Lease Agreements NumberOfCapitalizedLeaseAgreements	3
CY2014Q1	nhc	Number Of Facilities Under Capitalized Lease NumberOfFacilitiesUnderCapitalizedLease	3
CY2010Q4	nhc	Number Of Patient Beds In Facility NumberOfPatientBedsInFacility	120
CY2017Q4	nhc	Number Of Skilled Nursing Centers NumberOfSkilledNursingCenters	5
CY2017Q4	nhc	Number Of Variable Interest Entities NumberOfVariableInterestEntities	1
CY2017	nhc	Primary Insurance Coverage Amount Per Incident PrimaryInsuranceCoverageAmountPerIncident	1000000
CY2017	nhc	Primary Insurance Coverage Amount Per Location PrimaryInsuranceCoverageAmountPerLocation	3000000
CY2017	nhc	Proceeds From Payments For Tax Benefit Expense From Share Based Compensation ProceedsFromPaymentsForTaxBenefitExpenseFromShareBasedCompensation
CY2016	nhc	Proceeds From Payments For Tax Benefit Expense From Share Based Compensation ProceedsFromPaymentsForTaxBenefitExpenseFromShareBasedCompensation	-1096000
CY2015	nhc	Proceeds From Payments For Tax Benefit Expense From Share Based Compensation ProceedsFromPaymentsForTaxBenefitExpenseFromShareBasedCompensation	1942000
CY2017	nhc	Reduction Of Deferred Tax Asset Associated With Change In Federal Tax Rate ReductionOfDeferredTaxAssetAssociatedWithChangeInFederalTaxRate	2854000
CY2014Q1	nhc	Term Of Additional Lease Option TermOfAdditionalLeaseOption	P5Y
CY2017Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	17389000
CY2016Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	17019000
CY2016Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	18593000
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	86767000
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	82531000
CY2017Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	67102000
CY2016Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	65912000
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	409429000
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	373516000
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	108730000
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1729000
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3157000
CY2017Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	197453000
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	216144000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	77657000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	91211000
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	67504000
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	66068000
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	215659000
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	211457000
CY2016	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-1096000
CY2015	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	1942000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1982000
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	509000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1678000
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1678000
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	509000
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1982000
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5041000
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5743000
CY2017Q4	us-gaap	Assets Assets	1096526000
CY2016Q4	us-gaap	Assets Assets	1087447000
CY2017Q4	us-gaap	Assets Current AssetsCurrent	329311000
CY2016Q4	us-gaap	Assets Current AssetsCurrent	290857000
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	167277000
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	185968000
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	305480000
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	321717000
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	109756000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	76943000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	89269000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	70331000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	79827000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	70157000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	79502000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	797000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	749000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	796000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	717000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	18492000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	14181000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	18499000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	14216000
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	166395000
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	183704000
CY2017Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	603289000
CY2016Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	552404000
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3696000
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3481000
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	23052000
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	26748000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	32067000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	5200000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	5200000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	5200000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	5200000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	5200000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	6067000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	5319000
CY2014Q1	us-gaap	Capital Leases Future Minimum Payments Net Minimum Payments1 CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1	5200000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	26748000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59118000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26335000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38208000
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	35832000
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17725000
CY2015	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-31104000
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31589000
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49314000
CY2014Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80418000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67421000
CY2017	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.89
CY2016	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.75
CY2015	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.54
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15212133
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15212133
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15162938
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15162938
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	152000
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	152000
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	57641000
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	63242000
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	41899000
CY2017	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-523000
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Concentration of Credit Risks</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Our credit risks primarily relate to cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, marketable securities, restricted marketable securities and notes receivable. Cash and cash equivalents are primarily held in bank accounts and overnight investments. Restricted cash and cash equivalents is primarily invested in commercial paper and certificates of deposit with financial institutions and other interest-bearing accounts. Accounts receivable consist primarily of amounts due from patients (funded through Medicare, Medicaid, other contractual programs and through private payors) and from other health care companies for management, accounting and other services. We perform continual credit evaluations of our clients and maintain allowances for doubtful accounts on these accounts receivable. Marketable securities and restricted marketable securities are held primarily in accounts with brokerage institutions. Notes receivable relate primarily to secured loans with health care facilities (recorded as notes receivable in the consolidated balance sheets) as discussed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11.</div> </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">At any point in time we have funds in our operating accounts and restricted cash accounts that are with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party financial institutions. These balances in the U.S. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>exceed the Federal Deposit Insurance Corporation (FDIC) insurance limits. While we monitor the cash balances in our operating accounts, these cash and restricted cash balances could be impacted if the underlying financial institutions fail or could be subject to other adverse conditions in the financial markets. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Our financial instruments, principally our notes receivable, are subject to the possibility of loss of the carrying values as a result of the failure of other parties to perform according to their contractual obligations. We obtain various collateral and other protective rights, and continually monitor these rights in order to reduce such possibilities of loss. We evaluate the need to provide reserves for potential losses on our financial instruments based on management's periodic review of the portfolio on an instrument by instrument basis. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div> for additional information on the notes receivable.</div></div></div></div>
CY2017Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	13637000
CY2016Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	53705000
CY2017Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2887000
CY2016Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	3236000
CY2015	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	616757
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	912886000
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	866096000
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	839496000
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	23038000
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	24012000
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	29322000
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	25188000
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24673000
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	32890000
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2150000
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	661000
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3568000
CY2017Q4	us-gaap	Customer Refundable Fees CustomerRefundableFees	8827000
CY2016Q4	us-gaap	Customer Refundable Fees CustomerRefundableFees	9924000
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-6548000
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4208000
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-532000
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4714000
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4791000
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-648000
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	36053000
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	51700000
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3226000
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3362000
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	227000
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	788000
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-227000
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	2753000
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	3942000
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17677000
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	29628000
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	747000
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1262000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	607000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	387000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	5301000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	8642000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	5556000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	8907000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1304000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2077000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	1288000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	2277000
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	18376000
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	22072000
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1337000
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1481000
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	18376000
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	22072000
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2078000
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3135000
CY2017Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4867000
CY2016Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	5244000
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	42652000
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	39023000
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	37114000
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	42652000
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	39023000
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37114000
CY2015	us-gaap	Dividends Common Stock DividendsCommonStock	22252000
CY2016	us-gaap	Dividends Common Stock DividendsCommonStock	26617000
CY2017	us-gaap	Dividends Common Stock DividendsCommonStock	28716000
CY2017Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7297000
CY2016Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	6818000
CY2017	us-gaap	Dividends Preferred Stock DividendsPreferredStock
CY2016	us-gaap	Dividends Preferred Stock DividendsPreferredStock
CY2015	us-gaap	Dividends Preferred Stock DividendsPreferredStock	6819000
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.84
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.70
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.41
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.70
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.34
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.34
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.84
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.70
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.41
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.73
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.69
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.32
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.20
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.367
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.253
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	6989000
CY2017	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y
CY2017	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	933000
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5680000
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5263000
CY2017	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	7829000
CY2016	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	8059000
CY2015	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	6505000
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	23321000
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	21973000
CY2015Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	23213000
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	24928000
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	24787000
CY2015Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	26334000
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	8908000
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	8082000
CY2015Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	7970000
CY2017	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	7118000
CY2016	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	9177000
CY2015	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	9589000
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	10515000
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	10896000
CY2015Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	11091000
CY2017	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	52836000
CY2016	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	52105000
CY2015	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	50464000
CY2017Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	167564000
CY2017	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29300000
CY2017	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	262000
CY2016	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	816000
CY2015	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	566000
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30700000
CY2016Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	158558000
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34500000
CY2017Q4	us-gaap	Goodwill Goodwill	17600000
CY2016Q4	us-gaap	Goodwill Goodwill	17600000
CY2017	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	47153000
CY2016	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	45914000
CY2015	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	41776000
CY2017	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	919843000
CY2016	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	880724000
CY2015	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	864846000
CY2017Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	239243000
CY2017Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	239457000
CY2017Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	241985000
CY2017Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	246311000
CY2016Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	229588000
CY2016Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	227769000
CY2016Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	231281000
CY2016Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	238000000
CY2017	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	966996000
CY2016	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	926638000
CY2015	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	906622000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	74549000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	80207000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	85274000
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6932000
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6636000
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5845000
CY2017	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	-62000
CY2016	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	205000
CY2015	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	740000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18867000
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29669000
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32131000
CY2017	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-8488000
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-8488000
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	26092000
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	28072000
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	29846000
CY2017	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	204000
CY2016	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense
CY2015	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	230000
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	156000
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	351000
CY2017	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-338000
CY2016	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	283000
CY2015	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-372000
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2647000
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1783000
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1767000
	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	1753000
CY2017	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	613000
CY2016	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	716000
CY2015	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	2674000
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	23550000
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	27668000
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	29183000
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5465000
CY2016Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4665000
CY2017	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2615000
CY2016	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1535000
CY2015	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	4251000
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9492000
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4403000
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11835000
CY2017	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	1190000
CY2016	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	574000
CY2015	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	5479000
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-136000
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	47000
CY2015	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1524000
CY2016	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	402000
CY2015	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	406000
CY2017	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-7225000
CY2016	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	1597000
CY2015	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	2285000
CY2017	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	800000
CY2016	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	1462000
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-355000
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-60000
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	441000
CY2017	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	8408000
CY2016	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	4500000
CY2017	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2987000
CY2016	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1015000
CY2015	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-280000
CY2017	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-507000
CY2016	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	8000
CY2015	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	283000
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	796000
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	477000
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-89000
CY2017	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	3070000
CY2016	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	-4541000
CY2015	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	-7175000
CY2017	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares
CY2016	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	48303
CY2015	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	456323
CY2017	us-gaap	Interest Expense InterestExpense	4890000
CY2016	us-gaap	Interest Expense InterestExpense	3941000
CY2015	us-gaap	Interest Expense InterestExpense	2608000
CY2017	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	6474000
CY2016	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	5705000
CY2015	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	5494000
CY2017	us-gaap	Interest Paid Net InterestPaidNet	5183000
CY2016	us-gaap	Interest Paid Net InterestPaidNet	4528000
CY2015	us-gaap	Interest Paid Net InterestPaidNet	2965000
CY2017Q4	us-gaap	Inventory Net InventoryNet	7153000
CY2016Q4	us-gaap	Inventory Net InventoryNet	7508000
CY2017Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	36339000
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	37242000
CY2017	us-gaap	Labor And Related Expense LaborAndRelatedExpense	572043000
CY2016	us-gaap	Labor And Related Expense LaborAndRelatedExpense	548007000
CY2015	us-gaap	Labor And Related Expense LaborAndRelatedExpense	532735000
CY2017Q4	us-gaap	Land Land	59778000
CY2016Q4	us-gaap	Land Land	59812000
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	40367000
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	41292000
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	39967000
CY2017Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	114480000
CY2016Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	108661000
CY2010Q4	us-gaap	Lessee Leasing Arrangements Operating Leases Renewal Term LesseeLeasingArrangementsOperatingLeasesRenewalTerm	P5Y
CY2017	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P10Y
CY2010Q4	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P10Y
CY2017Q4	us-gaap	Liabilities Liabilities	393094000
CY2016Q4	us-gaap	Liabilities Liabilities	417836000
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1096526000
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1087447000
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	155065000
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	150928000
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	100000000
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	120000000
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	10000000
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
CY2017Q4	us-gaap	Malpractice Loss Contingency Number Of Claims MalpracticeLossContingencyNumberOfClaims	60
CY2017Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	139085000
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	138013000
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
CY2017Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	13251000
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	100000000
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	120000000
CY2017Q4	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	21012000
CY2016Q4	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	22773000
CY2017Q4	us-gaap	Marketable Securities Restricted Noncurrent MarketableSecuritiesRestrictedNoncurrent	145383000
CY2016Q4	us-gaap	Marketable Securities Restricted Noncurrent MarketableSecuritiesRestrictedNoncurrent	160931000
CY2017Q4	us-gaap	Minority Interest MinorityInterest	694000
CY2016Q4	us-gaap	Minority Interest MinorityInterest
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-49074000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-27131000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-41675000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9560000
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-81476000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-72784000
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	94466000
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	90882000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	83355000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	53143000
CY2016	us-gaap	Net Income Loss NetIncomeLoss	50538000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	56205000
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-523000
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12728000
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10655000
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11352000
CY2017Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	21470000
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13699000
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11866000
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11110000
CY2016Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13863000
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	56205000
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	50538000
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	46324000
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4768000
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5189000
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6090000
CY2017Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4392000
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4773000
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4925000
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5091000
CY2016Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4876000
CY2016Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	17079000
CY2010Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	4500000
CY2017Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1450000
CY2016Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	3259000
CY2017Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	11801000
CY2016Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	13820000
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2017	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2017Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	10
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15864000
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	12138000
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	9785000
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	16323000
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	17624000
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	14641000
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	10590000
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	17687000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	54110000
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	60542000
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	67126000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	313550000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	34200000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	34200000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	34200000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	34200000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	34200000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	142550000
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	217896000
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	236966000
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1436000
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	12704000
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-11244000
CY2017	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	262000
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	816000
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	566000
CY2017	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1019000
CY2016	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	8185000
CY2015	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-7062000
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2717000
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	21705000
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-17740000
CY2017	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	252934000
CY2016	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	233833000
CY2015	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	227072000
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16194000
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	13207000
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15795000
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16302000
CY2017	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	20439000
CY2016	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	19665000
CY2015	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	18148000
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	559624000
CY2017	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2016	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8195000
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
CY2017	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock
CY2016	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock
CY2015	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock	130538000
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	601000
CY2017	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	28237000
CY2016	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	25795000
CY2015	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	21089000
CY2017	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock
CY2016	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock
CY2015	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	8986000
CY2017	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	246000
CY2016	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	1282000
CY2015	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	674000
CY2017	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	202000
CY2016	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	5251000
CY2015	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	5676000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32347000
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	62601000
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	58416000
CY2017	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	31244000
CY2016	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	48620000
CY2015	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	60540000
CY2017	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact
CY2016	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact
CY2015	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	6819000
CY2017	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared
CY2016	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared
CY2015	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	0.64
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2864000
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2648000
CY2017	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	4282000
CY2016	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	1636000
CY2015	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	4948000
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2524000
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10772000
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10634000
CY2017	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
CY2016	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
CY2015	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	110000000
CY2017	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	1217000
CY2016	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders
CY2015	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders
CY2017	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	50197000
CY2016	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	34642000
CY2015	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	47574000
CY2017	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	50197000
CY2016	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	34642000
CY2015	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	47574000
CY2017	us-gaap	Profit Loss ProfitLoss	55682000
CY2016	us-gaap	Profit Loss ProfitLoss	50538000
CY2015	us-gaap	Profit Loss ProfitLoss	53143000
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	958748000
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	933140000
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	549319000
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5256000
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5967000
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6583000
CY2017	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	262000
CY2016	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	816000
CY2015	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	566000
CY2017	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	3481000
CY2016	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	3278000
CY2015	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	3089000
CY2017	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	20000000
CY2016	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit
CY2015	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8303000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5254000
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11106000
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	6397000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3125000
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1906000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2129000
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	419423000
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	391934000
CY2017	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Deferred Revenue </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Deferred revenue includes the deferred gain on the sale of assets to National (as discussed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) and entrance fees that have been and are currently being received upon reservation and occupancy in the independent living centers we operate. The non–refundable portion (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div>) of the entrance fee is included in deferred revenue and is being recognized over the remaining life expectancies of the residents.</div></div></div></div>
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	1678000
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	509000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	1982000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.031
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	48995
CY2015	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10634000
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10772000
CY2017Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	93275000
CY2016Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	91162000
CY2017Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	27409000
CY2016Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	25898000
CY2017Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	65866000
CY2016Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	65264000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0071
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	15000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	46.69
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0309
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0273
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.166
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.158
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.165
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0208
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0089
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	191907
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	61.63
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	933000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7431000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5447000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	656
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	72.94
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56210
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56291
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1125443
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	568000
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	954678
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	621390
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	177959
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1239407
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.92
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	48.15
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	55.48
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	71.19
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	47.06
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	47.16
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	51.25
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	61.47
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	62.54
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	72.96
CY2017	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
CY2017Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1239407
CY2017	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y292D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y73D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y73D
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	568000
CY2017Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	71.19
CY2017	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y328D
CY2017Q4	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	2645000
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	389498
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	499066
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	703432000
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2524000
CY2015	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	130538000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	702738000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	669611000
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	734148000
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	630996000
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	669611000
CY2016	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	8195000
CY2017Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	21384000
CY2016Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	21296000
CY2017	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-2508000
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1753000
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1368000
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2141000
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period.</div></div></div></div>
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15218962
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15206997
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14491433
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15189920
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15134518
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13889134

Files In Submission

Name	View Source	Status
0001437749-18-002879-index-headers.html	Edgar Link	pending
0001437749-18-002879-index.html	Edgar Link	pending
0001437749-18-002879.txt	Edgar Link	pending
0001437749-18-002879-xbrl.zip	Edgar Link	pending
banner.jpg	Edgar Link	pending
ex_104786.htm	Edgar Link	pending
ex_104787.htm	Edgar Link	pending
ex_104788.htm	Edgar Link	pending
ex_104789.htm	Edgar Link	pending
ex_104790.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhc-20171231.xml	Edgar Link	completed
nhc-20171231.xsd	Edgar Link	pending
nhc-20171231_cal.xml	Edgar Link	unprocessable
nhc-20171231_def.xml	Edgar Link	unprocessable
nhc-20171231_lab.xml	Edgar Link	unprocessable
nhc-20171231_pre.xml	Edgar Link	unprocessable
nhc20171231_10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
return.jpg	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

2016 Q4 Form 10-K Financial Statement

#000143774918002879 Filed on February 20, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC NATIONAL HEALTHCARE CORP Stock $nhc

2016 Q4 Form 10-K Financial Statement

#000143774918002879 Filed on February 20, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc